Cargando…

Profiling non-coding RNA expression in cerebrospinal fluid of amyotrophic lateral sclerosis patients

INTRODUCTION: Objective biomarkers for the fatal neurodegenerative disease amyotrophic lateral sclerosis or motor neuron disease (ALS/MND) are critical for diagnosis, drug development, clinical trials, and insight into disease pathology. Key candidates for biomarkers present in biofluids include non...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joilin, Greig, Gray, Elizabeth, Thompson, Alexander G., Talbot, Kevin, Leigh, P. Nigel, Newbury, Sarah F., Turner, Martin R., Hafezparast, Majid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Medical Genetics & Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629092/ https://www.ncbi.nlm.nih.gov/pubmed/36314539 http://dx.doi.org/10.1080/07853890.2022.2138530

Ejemplares similares

Identification of a potential non-coding RNA biomarker signature for amyotrophic lateral sclerosis
por: Joilin, Greig, et al.
Publicado: (2020)

Potential of activated microglia as a source of dysregulated extracellular microRNAs contributing to neurodegeneration in amyotrophic lateral sclerosis
por: Christoforidou, Eleni, et al.
Publicado: (2020)

An Overview of MicroRNAs as Biomarkers of ALS
por: Joilin, Greig, et al.
Publicado: (2019)

Corrigendum: An Overview of MicroRNAs as Biomarkers of ALS
por: Joilin, Greig, et al.
Publicado: (2019)

The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis
por: Gray, Elizabeth, et al.
Publicado: (2015)

Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis
por: Dreger, Marie, et al.
Publicado: (2022)

Proteomic analysis of cerebrospinal fluid in amyotrophic lateral sclerosis
por: CHEN, YAN, et al.
Publicado: (2016)

Cerebrospinal Fluid Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis
por: Costa, Júlia, et al.
Publicado: (2021)

Biomarkers in cerebrospinal fluid for amyotrophic lateral sclerosis phenotypes
por: Zhou, Jinxia, et al.
Publicado: (2023)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Neurofilament markers in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
por: Shi, Jiaying, et al.
Publicado: (2021)

PARP-1 dependent recruitment of the amyotrophic lateral sclerosis-associated protein FUS/TLS to sites of oxidative DNA damage
por: Rulten, Stuart L., et al.
Publicado: (2014)

Cerebrospinal Fluid Biomarkers for Kii Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex
por: Nakayama, Yui, et al.
Publicado: (2013)

Increased cerebrospinal fluid adenosine 5'-triphosphate in patients with amyotrophic lateral sclerosis
por: Nukui, Takamasa, et al.
Publicado: (2021)

Sweet food preference in amyotrophic lateral sclerosis
por: Turner, Martin R, et al.
Publicado: (2017)

Amyotrophic lateral sclerosis: the complex path to precision medicine
por: Talbot, Kevin, et al.
Publicado: (2018)

CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis
por: Gray, Elizabeth, et al.
Publicado: (2020)

Cerebrospinal fluid from patients with amyotrophic lateral sclerosis inhibits sonic hedgehog function
por: Drannik, Anna, et al.
Publicado: (2017)

Cerebrospinal fluid cytotoxicity in amyotrophic lateral sclerosis: a systematic review of in vitro studies
por: Ng Kee Kwong, Koy Chong, et al.
Publicado: (2020)

Monoaminergic and Kynurenergic Characterization of Frontotemporal Dementia and Amyotrophic Lateral Sclerosis in Cerebrospinal Fluid and Serum
por: Janssens, Jana, et al.
Publicado: (2020)

Non-invasive MRI quantification of cerebrospinal fluid dynamics in amyotrophic lateral sclerosis patients
por: Sass, Lucas R., et al.
Publicado: (2020)

Lipidomic traits of plasma and cerebrospinal fluid in amyotrophic lateral sclerosis correlate with disease progression
por: Sol, Joaquim, et al.
Publicado: (2021)

Psychiatric disorders prior to amyotrophic lateral sclerosis
por: Turner, Martin R., et al.
Publicado: (2016)

Disease-Related Changes in the Cerebrospinal Fluid Metabolome in Amyotrophic Lateral Sclerosis Detected by GC/TOFMS
por: Wuolikainen, Anna, et al.
Publicado: (2011)

Measurement of cystatin C functional activity in the cerebrospinal fluid of amyotrophic lateral sclerosis and control subjects
por: Wilson, Meghan E, et al.
Publicado: (2013)

Evidence for Fungal Infection in Cerebrospinal Fluid and Brain Tissue from Patients with Amyotrophic Lateral Sclerosis
por: Alonso, Ruth, et al.
Publicado: (2015)

Adiponectin levels in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients: possible influence on neuroinflammation?
por: Bossolasco, Patrizia, et al.
Publicado: (2017)

Human Spinal Motor Neurons Are Particularly Vulnerable to Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis Patients
por: Bräuer, Stefan, et al.
Publicado: (2020)

Defective cholesterol metabolism in amyotrophic lateral sclerosis
por: Abdel-Khalik, Jonas, et al.
Publicado: (2017)

Quantitative FLAIR MRI in Amyotrophic Lateral Sclerosis
por: Fabes, Jeremy, et al.
Publicado: (2017)

Myelin imaging in amyotrophic and primary lateral sclerosis
por: Kolind, Shannon, et al.
Publicado: (2013)

Cronobacter sakazakii DNA Detection in Cerebrospinal Fluid of a Patient with Amyotrophic Lateral Sclerosis Mimic Syndrome
por: Piombo, Marianna, et al.
Publicado: (2015)

Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid
por: Otake, Kentaro, et al.
Publicado: (2019)

Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis
por: Tokuda, Eiichi, et al.
Publicado: (2019)

Genotyping and Plasma/Cerebrospinal Fluid Profiling of a Cohort of Frontotemporal Dementia–Amyotrophic Lateral Sclerosis Patients
por: Bourbouli, Mara, et al.
Publicado: (2021)

Elevated Cerebrospinal Fluid Proteins and Albumin Determine a Poor Prognosis for Spinal Amyotrophic Lateral Sclerosis
por: Assialioui, Abdelilah, et al.
Publicado: (2022)

Cerebrovascular injury as a risk factor for amyotrophic lateral sclerosis
por: Turner, Martin R, et al.
Publicado: (2016)

A proposed staging system for amyotrophic lateral sclerosis
por: Roche, Jose C., et al.
Publicado: (2012)

Astroglia acquires a toxic neuroinflammatory role in response to the cerebrospinal fluid from amyotrophic lateral sclerosis patients
por: Mishra, Pooja-Shree, et al.
Publicado: (2016)

YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression
por: Andrés-Benito, Pol, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hdrgu3numu1c6cs7l1q32tetb6